Jochen Brumm
Impact in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Surgery top 5%
- Lipoproteins and Cardiovascular Health
- Cholesterol and Lipid Metabolism
Papers in
-
- Biosimilars and Bioanalytical Methods 7
- Oncology 9
- CAR-T cell therapy research 5
- Co-authors
- John J.V. McMurray (1 shared paper)BERNARD R. CHAITMAN (1 shared paper)Hardi Mundl (1 shared paper)Jean‐Claude Tardif (1 shared paper)Christie Mitchell Ballantyne (1 shared paper)Markus Abt (1 shared paper)Stephen James Nicholls (1 shared paper)Prediman Krishan Shah (1 shared paper)
- Journals
- mAbs (4 papers)Bioanalysis (4 papers)PLoS ONE (2 papers)FEMS Yeast Research (1 paper)Risk Analysis (1 paper)
- Partner nations
- United StatesCanadaSwitzerland
In The Last Decade
Jochen Brumm
31 papers receiving 2.4k citations
Jochen Brumm's Hit Papers
Peers
Comparison fields: 5 of 121
- Endocrinology, Diabetes and Metabolism 717
- Surgery 969
- Cancer Research 279
- Cardiology and Cardiovascular Medicine 307
- Immunology 281
Countries citing papers authored by Jochen Brumm
This map shows the geographic impact of Jochen Brumm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jochen Brumm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jochen Brumm more than expected).
Fields of papers citing papers by Jochen Brumm
This network shows the impact of papers produced by Jochen Brumm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jochen Brumm. The network helps show where Jochen Brumm may publish in the future.
Co-authors
The 25 scholars most cited alongside Jochen Brumm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome Hit paper breakdown → | 2012 | 1686 |
| 2 | 2008 | 157 | |
| 3 | 2017 | 114 | |
| 4 | 2001 | 104 | |
| 5 | 2019 | 90 | |
| 6 | 2019 | 78 | |
| 7 | 2019 | 53 | |
| 8 | 2002 | 40 | |
| 9 | 2021 | 40 | |
| 10 | 2021 | 27 | |
| 11 | 2008 | 27 | |
| 12 | 2005 | 22 | |
| 13 | 2021 | 16 | |
| 14 | 2018 | 15 | |
| 15 | 2018 | 12 | |
| 16 | 2024 | 11 | |
| 17 | 2022 | 11 | |
| 18 | 2022 | 11 | |
| 19 | 2008 | 10 | |
| 20 | 2019 | 8 |
About Jochen Brumm
Jochen Brumm is a scholar working on Immunology, Oncology, Biophysics, Radiology, Nuclear Medicine and Imaging and Endocrinology, Diabetes and Metabolism, having authored 32 papers that have together received 2.6k indexed citations. Recurring topics across this work include Biosimilars and Bioanalytical Methods (7 papers), Monoclonal and Polyclonal Antibodies Research (6 papers), CAR-T cell therapy research (5 papers), Protein purification and stability (4 papers), Cell Image Analysis Techniques (4 papers), Bioinformatics and Genomic Networks (3 papers), Computational Drug Discovery Methods (2 papers) and Asthma and respiratory diseases (2 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (717 citations), Surgery (969 citations), Cancer Research (279 citations), Cardiology and Cardiovascular Medicine (307 citations) and Immunology (281 citations). Jochen Brumm has collaborated with scholars based in United States, Canada and Switzerland. Frequent co-authors include John J.V. McMurray, BERNARD R. CHAITMAN, Hardi Mundl, Jean‐Claude Tardif, Christie Mitchell Ballantyne, Markus Abt, Stephen James Nicholls, Prediman Krishan Shah, Lawrence A. Leiter and Gregory G. Schwartz. Their work appears in journals such as mAbs, Bioanalysis, PLoS ONE, FEMS Yeast Research and Risk Analysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.